anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Source Note

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 110,355
Current window 65,011-65,040
Pages 3,679
Rows per page 30
Component: Source Noteclear collectionreset all
18 30 60

Component

65,011-65,040 of 110,355

filter-aware
12
The slide categorizes partnerships into clinical stage and pre-clinical programs, detailing the nature of the collaboration (e.g., cost/profit share, royalties).BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Loop · Golden Circle1 hit
17
Includes product image and key performance metrics.BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Beat · Market SizeLoop · Golden Circle1 hit
18
Slide highlights both historical traction (>3.6bn doses) and future growth vectors (label expansion, boosters, next-gen vaccines).BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Beat · Market SizeLoop · Golden Circle1 hit
20
The chart uses a horizontal bar representation to indicate the clinical stage of each program.BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Beat · ProductLoop · Golden Circle1 hit
23
The slide uses a Gantt-style visualization to show clinical trial phases for various drug candidates.BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Beat · ProductLoop · Golden Circle1 hit
24
The slide uses a matrix structure to compare different drug development programs.BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Beat · ProductLoop · Golden Circle1 hit
26
The slide uses a grouped table structure to categorize milestones by therapeutic area (COVID-19, Infectious Disease, Oncology, Data Updates).BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Beat · The AskLoop · Golden Circle1 hit
27
The slide uses a column-based layout to categorize strategic initiatives, with a footer highlighting foundational enablers.BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Beat · The AskLoop · Golden Circle1 hit
08
BioNTech | Results Presentation Deck | 32 slidesBioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations 1 hit
10
The chart shows the rapid succession of Omicron sub-lineages in the USA between Dec 2021 and June 2022.BioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
11
The slide uses a process-oriented layout to show how three workstreams converge into a single launch event.BioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
13
Data shows monovalent BA.1 and bivalent vaccines as 4th doses; includes LOD line and statistical superiority/non-inferiority notes.BioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
15
The chart uses a logarithmic scale for the y-axis (pVN50 titer).BioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
17
The slide uses a Gantt-style visualization to represent clinical trial phases for various drug candidates.BioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations 1 hit
18
The slide uses a process flow diagram to illustrate patient stratification into different treatment cohorts.BioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations 1 hit
19
Includes a citation to a Nature Medicine paper and a pipeline table.BioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations 1 hit
20
Includes bar chart of neoantigen counts, line chart of immune response over time, and Kaplan-Meier survival curve.BioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations 1 hit
21
The slide highlights the mechanism of action for bispecific antibodies and a monospecific HexaBody, emphasizing their role in T cell and NK cell activation.BioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations 1 hit
23
BioNTech | Results Presentation Deck | 32 slidesBioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations 1 hit
25
Includes earnings per share data and footnotes regarding rounding and collaboration profit sharing.BioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations 1 hit
26
BioNTech | Results Presentation Deck | 32 slidesBioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations 1 hit
28
Includes footnotes detailing market definitions and data sources.BioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations 1 hit
29
BioNTech | Results Presentation Deck | 32 slidesBioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations 1 hit
30
The slide uses a grouped table structure to categorize milestones by therapeutic area.BioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations 1 hit
05
Includes detailed footnotes defining the metrics.Blue Apron | Results Presentation Deck | 25 slides · Blue Apron
Conference presentation Investor relations Beat · Current State1 hit
07
This appears to be a slide from a pitch deck or investor presentation illustrating the product offering and pricing model.Blue Apron | Results Presentation Deck | 25 slides · Blue Apron
Conference presentation Investor relations Beat · Areas for ImprovementLoop · Zoom In1 hit
08
The chart highlights the 'Total Purchase Required' vs 'Sum of Ingredients Used' to illustrate the inefficiency of buying individual ingredients for a single recipe.Blue Apron | Results Presentation Deck | 25 slides · Blue Apron
Conference presentation Investor relations Beat · Areas for ImprovementLoop · Zoom In1 hit
09
The chart uses a dashed horizontal line to visually anchor the Blue Apron price point against the higher-priced restaurant alternatives.Blue Apron | Results Presentation Deck | 25 slides · Blue Apron
Conference presentation Investor relations Beat · Areas for ImprovementLoop · Zoom In1 hit
14
Uses a three-column layout to categorize ESG progress.Blue Apron | Results Presentation Deck | 25 slides · Blue Apron
Conference presentation Investor relations Beat · Strategic Initiatives1 hit
19
The slide presents two key performance indicators over a five-quarter period.Blue Apron | Results Presentation Deck | 25 slides · Blue Apron
Conference presentation Investor relations Beat · Strategic Initiatives1 hit